Literature DB >> 12742421

Using fructose-1,6-diphosphate during hypothermic rabbit-heart preservation: a high-energy phosphate study.

Dongping Hua1, Xingmei Zhuang, Jiusheng Ye, Dorothy Wilson, Benjamin Chiang, Sufan Chien.   

Abstract

BACKGROUND: In this study, we evaluated the effects of fructose-1,6-diphosphate (FDP) on high-energy phosphate metabolism during 18-hour hypothermic rabbit-heart preservation.
METHODS: Under general anesthesia and artificial ventilation, hearts from 42 adult New Zealand white rabbits were harvested, flushed, and preserved in St. Thomas solution at 4(o)C for 18 hours. In the study group (n = 15), FDP (5 mmol/liter) was added to the St. Thomas solution, whereas in the control group (n = 17), fructose (5 mmol/liter) was added. Another 10 hearts did not undergo hypothermic storage, but were used as the normal group for high-energy phosphate concentration comparison.
RESULTS: After 18 hours of hypothermic preservation, myocardial high-energy phosphate content decreased in both preservation groups. In the study group, left ventricular adenosine triphosphate (ATP) content was 33% of that in the normal hearts, but in the control group, ATP decreased to 14% of normal. Adenosine diphosphate (ADP) content, energy charge, and ATP-to-ADP ratio showed similar decreases. The high-energy phosphate profile (content in the atria and ventricles and the ratio of ATP to ADP to AMP) was maintained in the study group but not in the control group. High-energy phosphate metabolites such as inosine monophosphate (IMP), inosine, and hypoxanthine increased in both preservation groups, but the increase was more prominent in the control group.
CONCLUSION: Adding FDP to St. Thomas solution attenuated the depletion of high-energy phosphate concentration in the preserved hearts. This difference was especially prominent in the left and right ventricles. The protective effect of FDP during hypothermic heart preservation deserves further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742421     DOI: 10.1016/s1053-2498(02)00661-7

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Characterization of the high-affinity uptake of fructose-1,6-bisphosphate by cardiac myocytes.

Authors:  Thomas J Wheeler; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2012-03-18       Impact factor: 3.396

2.  Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.

Authors:  Bo Ma; Qi Zhang; Di Wu; Yong-lu Wang; Ying-ying Hu; Yan-ping Cheng; Zhen-dong Yang; Ya-ya Zheng; Han-Jie Ying
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

3.  Effects of fructose-1,6-diphosphate on concentration of calcium and activities of sarcoplosnic Ca2+-ATPase in cardiomyocytes of Adriamycin-treated rats.

Authors:  Wei Cai; Jun-zhu Chen; Li-ming Ruan; Yi-na Wang
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

4.  Permeability of fructose-1,6-bisphosphate in liposomes and cardiac myocytes.

Authors:  Thomas J Wheeler; John M McCurdy; Aaron denDekker; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

5.  Protection of rat cardiac myocytes by fructose-1,6-bisphosphate and 2,3-butanedione.

Authors:  Thomas J Wheeler; Sufan Chien
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Altered expression profile of glycolytic enzymes during testicular ischemia reperfusion injury is associated with the p53/TIGAR pathway: effect of fructose 1,6-diphosphate.

Authors:  May Al-Maghrebi; Waleed M Renno
Journal:  PeerJ       Date:  2016-07-05       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.